Drug Trial Radar · NCT02128633
Effectiveness of a Homecare Dentin Hypersensitivity Gel
Last checked: Nov 19, 2026Latest source record: May 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
126
Actual
Start
Nov 2009
Primary completion
Jun 2013
Study completion Mar 2014
Sponsor
- Lead sponsor
- Universidade Federal de Santa MariaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Franciscan University Center
- First posted
- May 1, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Aim: To evaluate the effectiveness of a desensitizing gel for topical and home use in the treatment of dentin hypersensitivity (DH) through a randomized clinical trial, double-blind, with three parallel treatment. Methods: 126 subjects were divided into three groups: placebo gel (PG), test gel (TG) (5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%) and sodium fluoride gel (2% FG ). The measurement of DH was performed by a single examiner blinded by the visual analog scale (VAS) after tactile, thermal and osmotic stimuli in the Baseline, 7, 15 and 30 days.
Conditions
- Dentin Sensitivity
Interventions
placebo gelDrug
Manipulated at Novaderme ®, Santa Maria, RS, Brazil.
5% sodium fluoride, potassium oxalate 5%, strontium chloride 10%Drug
Manipulated at Novaderme ®, Santa Maria, RS, Brazil.
Fluoride neutral NaF gel 2 %Drug
The product had similar appearance and viscosity than others.
Primary outcomes
What the sponsor says the trial is designed to measure.
- dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 7 days.
- dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 15 days.
- dentine hypersensitivity with visual analog scale (VAS) following tactile, thermal and osmotic stimulusTime frame: Change from Baseline in VAS Scale at 30 days.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fabricio Batistin Zanatta
Santa Maria, Rua Floriano Peixoto--, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.